TAZEMETOSTAT | TAZEMETOSTAT | ATC L01XX72
ANTINEOPLASTIC METHYLTRANSFERASE INHIBITOR TREATMENT OF METASTATIC OR LOCAL ADVANCED EPITHELIOID SARCOMA NOT ELIGIBLE FOR COMPLETE RESECTION | ORAL | Cmax 1.45 MICROMOLAR Tmax 1.5 HOUR F 33 PERCENT VD 1230 LITER PPB 88 PERCENT Cl 274 LITER / HOUR HT 3.1 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER | METHYLTRANSFERASE EZH2 | Histone-lysine N-methyltransferase EZH2 UNIPROT Q15910 EZH2 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |